Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer - sprookjes - yvandenbroek - TriplyDB

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer

http://www.wikidata.org/entity/Q24652213

about

Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.A resampling-based meta-analysis for detection of differential gene expression in breast cancer Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.Elevated endogenous expression of the dominant negative basic helix-loop-helix protein ID1 correlates with significant centrosome abnormalities in human tumor cells.Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis Epigenetic Signatures in Breast Cancer: Clinical Perspective Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.Epstein-Barr virus-specific methylation of human genes in gastric cancer cells.Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer Clinical implications of the quantitative detection of ID4 gene methylation in myelodysplastic syndrome.Identification of thyroid carcinoma related genes with mRMR and shortest path approaches.Clinically relevant microRNAs in ovarian cancer The mitogen-activated protein kinase phosphatase-1 (MKP-1) gene is a potential methylation biomarker for malignancy of breast cancer.Hypomethylation of DNA-binding inhibitor 4 serves as a potential biomarker in distinguishing acquired tamoxifen-refractory breast cancer A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR.Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia DNA methylation: its role in cancer development and therapy.Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.ITIH5 mediates epigenetic reprogramming of breast cancer cells.Emerging promise of epigenetics and DNA methylation for the diagnosis and management of women's cancers.Inhibitor of differentiation 4 (ID4): From development to cancer Increased inhibitor of differentiation 4 (id4) expression in glioblastoma: a tissue microarray study.ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype.Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.Epigenetic regulation of ID4 in the determination of the BRCAness phenotype in breast cancer.EZH2 dependent H3K27me3 is involved in epigenetic silencing of ID4 in prostate cancer.Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function.Id4 dependent acetylation restores mutant-p53 transcriptional activity.The Id-protein family in developmental and cancer-associated pathways.Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients.Nuclear transport receptor karyopherin-α2 promotes malignant breast cancer phenotypes in vitro.ID4 is frequently downregulated and partially hypermethylated in prostate cancer.Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.ID4: a new player in the cancer arena.Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.miRNA-342 Regulates CEACAM1-induced Lumen Formation in a Three-dimensional Model of Mammary Gland Morphogenesis.

P2860

Q21260384-142E4199-D691-41D6-BE81-6EA87BA0DDC5 Q28582796-55ACDBEE-8703-4017-8CE2-9B18FEB491FD Q28592943-E00BBBCF-C85F-4F9B-8E19-11203EAEEF70 Q30502257-8C60869A-5C30-4C52-B89E-3F8ED12EC682 Q33396580-CDE328F6-234B-4B9F-82AB-E8CD8D2C90A8 Q33462003-9B7FA7BA-5733-497E-838F-BA1679CEB906 Q33523638-1937EEF6-B29D-4F9D-ACAB-DA9D49DF2CC3 Q33739319-0D793BF0-EA28-46F9-8C8C-DC532E2660C1 Q34095995-F2848B99-2605-4F69-8D53-32E98CAFC4D3 Q34489002-E84027FB-CB0D-4D93-8195-FE5DBE17CFFD Q34504229-69D41F82-09C9-42F1-B88D-2570EC6D8658 Q34557974-BE1C5A6C-3D22-4716-89BC-50557A56CC72 Q34559594-28E49989-4ADD-4D5B-BA6A-E1E5FAA5A299 Q35108501-2FB722D3-98DC-467F-A929-5DDA6C1C16C3 Q35144091-674D3B6A-235C-45D3-ACCF-97D8F52FB792 Q35204609-3FDB8C58-889E-4DE0-977D-DDF0F070AB66 Q36005081-98B9904E-9B4E-4732-B32E-A0AA2F399A14 Q36095385-966B0624-3ABD-4A9A-9A38-00099E8DFB01 Q36149242-1DF301AB-0C6D-4A69-8985-E471508D12C8 Q36477232-511F44B7-45A9-4759-9739-806DDEC89A80 Q36986433-1F0287F5-654D-4B08-848E-25251E7D0B5C Q37439940-6D52FE55-1EB4-4095-AEF5-2DDE7BB9B9F7 Q37661492-9D618C4B-2C9B-48EB-85F6-20F0C616D98B Q37962013-88C60444-D4AE-4CA1-A38C-9BDF8E7D7C95 Q38289940-66A3578E-D61E-4072-8DC5-B6A12E091AB1 Q38414727-3308B896-5046-424E-93BA-B652F5B24ABE Q38894487-0B14D6DF-3CE3-4FD2-AC8E-09AA57E8BEA1 Q38898841-3A2A23A5-5DA7-434B-BC3E-1D8FA952F265 Q38938253-D66819EB-ADA4-4122-8D2F-609DA82B4042 Q38966904-4C515CE8-400E-46C4-AAC9-CA75EAF11FB2 Q39035362-2D352D1B-B29A-435B-82BE-C7AF7671FA37 Q39044368-2DFC9F36-2664-4FC1-838E-1CBA072A61E3 Q39103288-BE115156-94AB-42FE-B01E-97161F80439F Q39395200-14AE4D88-6EED-4C0A-9962-F49A5F52B629 Q39475921-3AECAF2A-D383-4203-BE63-A2C7627E6AFB Q39481269-C04F9BD7-8964-47B2-AB02-48C30CFD11A5 Q39625095-A7C7D315-C3B8-4E68-B590-0AAA6AAE5CF9 Q40580196-A1240827-A464-4F74-875F-CFC58042EA4D Q41241298-5672B589-8BE5-43BC-A7CA-0AFDA5271C03 Q41817629-2DED97DD-D656-44C5-9CE8-CB2D1685B1E4

P2860

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer

http://www.wikidata.org/entity/Q24652213

description

2008 nî lūn-bûn

@nan

2008 թուականին հրատարակուած գիտական յօդուած

@hyw

2008 թվականին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Promoter methylation-associate ...... urrence in human breast cancer

@ast

Promoter methylation-associate ...... urrence in human breast cancer

@en

Promoter methylation-associate ...... urrence in human breast cancer

@nl

type

label

Promoter methylation-associate ...... urrence in human breast cancer

@ast

Promoter methylation-associate ...... urrence in human breast cancer

@en

Promoter methylation-associate ...... urrence in human breast cancer

@nl

altLabel

Promoter methylation-associate ...... urrence in human breast cancer

@en

prefLabel

Promoter methylation-associate ...... urrence in human breast cancer

@ast

Promoter methylation-associate ...... urrence in human breast cancer

@en

Promoter methylation-associate ...... urrence in human breast cancer

@nl

P1433

Q24652213-6B5D13F7-DED0-4A70-8D9F-41D527D12D52

P1476

Q24652213-F9F06D1A-67E1-405B-B217-6EFCC9FE9126

P2093

Q24652213-602281D3-318E-40EC-A43C-7420A7F67160

Q24652213-64FE1784-F5A9-4381-A88F-5756E589F9CE

Q24652213-A3470461-7F51-48C3-B7C7-FB3A18857115

Q24652213-A3B82195-3393-419A-8C62-4FD4375A8F5C

Q24652213-EE54AC2F-99F4-4F81-8EC4-037EB91423A0

P2860

Q24652213-00E7E973-5145-43F8-BC78-D56B4433B378

Q24652213-0A7684BF-3AA2-4F11-8022-C78E9CE82888

Q24652213-0C8E66B7-D10A-4406-9C27-B5ACE8B0EF19

Q24652213-0EF761F7-355F-4B6E-A86A-B2D8CE6FBCC8

Q24652213-0FA9203B-CF3D-4874-AAC7-3E4993985D3F

Q24652213-159C11B9-9841-45CD-A5AA-B48C7B2816A2

Q24652213-2AF769E6-0A7C-48F7-B231-BF7A076763DC

Q24652213-2D080B7F-40BD-44E8-B85C-5B5A2311ECE1

Q24652213-4061307D-BEBE-48F2-BD70-CEA8DBE1F737

Q24652213-40B339A1-6009-4B63-9B32-86EA6125A03F

P2888

Q24652213-1E26AF21-94DF-44A4-BBC2-A16C8F332A26

P304

Q24652213-092E6CAF-865E-4338-8DD3-5C7ECF6923B6

P31

Q24652213-B28EB002-E1F4-4195-99E3-4DE1D74F882E

P3181

Q24652213-EF59D90A-FDB4-46E0-B0E3-3EDEC6CFE2EF

P356

Q24652213-954D7C92-B4E5-474B-ADC6-4FE925C4B220

P407

Q24652213-444D4E81-3BF0-4EB3-9823-7BAFB363BF6E

P433

Q24652213-5E2BEF55-D524-4AA1-927F-16383C7EBB32

P478

Q24652213-CA466738-41B3-4497-851E-B5877575B1A1

P50

Q24652213-1D283476-FFF7-449B-9F67-FCA184F1022F

Q24652213-5B02847F-B280-4900-8123-7BE6B6F809A9

Q24652213-8B6050AD-B370-47BB-A48E-1809CFC11794

P577

Q24652213-8CAE3984-6A6E-44B7-87B1-B7C6EAF07A12

P5875

Q24652213-F5D79315-1D84-45ED-95DA-4778761801F1

P6179

Q24652213-5B1A5C1F-97CF-41A4-841A-DDB59573F607

P698

Q24652213-359DEED5-02B5-4426-BA19-AAE5528D37E3

P932

Q24652213-58DA034E-F5B4-45E5-9F44-292554045525

P3181

P356

1471-2407-8-154

P1433

P1476

Promoter methylation-associate ...... urrence in human breast cancer

@en

P2093

Arndt Hartmann

http://www.w3.org/2001/XMLSchema#string

Dieter Niederacher

http://www.w3.org/2001/XMLSchema#string

Erik Noetzel

http://www.w3.org/2001/XMLSchema#string

Felicitas Horn

http://www.w3.org/2001/XMLSchema#string

Oliver Galm

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach

High sensitivity mapping of methylated cytosines

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

Id4 regulates mammary epithelial cell growth and differentiation and is overexpressed in rat mammary gland carcinomas

The power and the promise of DNA methylation markers

Id proteins in cell cycle control and cellular senescence

Id proteins at the cross-road of development and cancer

The epigenomics of cancer

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis

Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas

P2888

1471-2407-8-154

P304

154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

208707

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1471-2407-8-154

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Ruth Knüchel-Clarke

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5329365

http://www.w3.org/2001/XMLSchema#string

P6179

1041049236

http://www.w3.org/2001/XMLSchema#string

P698

18513385

http://www.w3.org/2001/XMLSchema#string

P932

2435120

http://www.w3.org/2001/XMLSchema#string